The pathogenesis of Achilles tendinopathy: A systematic review

Foot and Ankle Surgery

Volumn 20, Issue 3, 2014, Pages 154-159

  Magnan, Bruno ^a   Bondi, Manuel ^a,b   Pierantoni, Silvia ^a   Samaila, Elena ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

Author keywords

Achilles pathogenesis; Achilles tendinopathy; Achilles tendon; Tendon degeneration

Indexed keywords

CORTICOSTEROID; MATRIX METALLOPROTEINASE; NITRIC OXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ACHILLES TENDINITIS; AGE DISTRIBUTION; ANATOMICAL VARIATION; ANGIOGENESIS; BIOMECHANICS; BODY COMPOSITION; BODY WEIGHT; CYTOKINE PRODUCTION; DEGENERATION; ENVIRONMENTAL FACTOR; FACTUAL DATABASE; GENDER; GENETIC PREDISPOSITION; HUMAN; LIMB DISEASE; MEDICAL HISTORY; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; NEUROLOGIC DISEASE; NONHUMAN; OVEREXERTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STEM CELL; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TEMPERATURE; TENDON FLEXIBILITY; TENDON OVERUSE; TENDON STEM CELL; TENDON TEMPERATURE; VASCULARIZATION; ACHILLES TENDON; TENDINOPATHY;

ACHILLES TENDON; HUMANS; RISK FACTORS; TENDINOPATHY;

EID: 84905572035     PISSN: 12687731     EISSN: 14609584     Source Type: Journal    
DOI: 10.1016/j.fas.2014.02.010     Document Type: Review

References (139)

1. Tishya A.L.W., Scott A.Y., Gary S.B., Dennis R.C. Mechanical properties of the human Achilles tendon. Clin Biomech 2001, 245-251.
2. Jòzsa L., Kannus P. Overuse injuries of tendons. Human tendons: anatomy, physiology and pathology 1997, 164-253. Human Kinetics, Champaign. L. Jòzsa, P. Kannus (Eds.).
3. Sharma P., Maffulli N. Understanding and managing Achilles tendinopathy. Br J Hosp Med (London) 2006, 67(2):64-67.
4. Ames P.R., Longo U.G., Denaro V., Maffulli N. Achilles tendon problems: not just an orthopaedic issue. Disabil Rehabil 2008, 30:1646-1650.
5. Kvist M. Achilles tendon injuries in athletes. Sports Med 1994, 18(3):173-201.
6. el Hawary R., Stanish W.D., Curwin S.L. Rehabilitation of tendon injuries in sport. Sports Med 1997, 24(5):347-358.
7. van Dijk C.N., van Sterkenburg M.N., Wiegerinck J.I., Karlsson J., Maffulli N. Terminology for Achilles tendon related disorders. Knee Surg Sports Traumatol Arthrosc 2011, 19:835-841.
8. Maayke N., van Sterkenburg C., Niek van Dijk. Mid portion Achilles tendinopathy: why painful? An evidence-based philosophy. Knee Surg Sports Traumatol Arthrosc 2011, 19:1367-1375.
9. Sharma P., Maffulli N. Basic biology of tendon injury, clinical review. Surgeon 2005, 3(5):309-316.
10. Wang James H-C., Guo Qianping, Li Bin Tendon biomechanics and mechanobiology-a minireview of basic concepts and recent advancements. J Hand Ther 2012, 25(April (2)):133-141.
11. Pufe T., Petersen W.J., Mentlein R., Tillmann B.N. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand J Med Sci Sports 2005, 15:211-222.
12. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Review. Rheumatology 2004, 43:131-142.
13. Cook J.L., Khan K.M., Purdam C. Achilles tendinopathy. Man Ther 2002, 7:121-130.
14. Ippolito E., Natali P.G., Postacchini F., Accini L., de Martino C. Morphological, immunological and biochemical study of rabbit Achilles tendon at various ages. J Bone Joint Surg 1980, 62A:583-598.
15. Riley G.P., Harrall R.L., Constant C.R., Chard M.D., Cawston T.E., Hazleman B.L. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 1994, 53:359-366.
16. Moore M.J., De Beaux A. A quantitative ultrastructural study of rat tendon from birth to maturity. J Anat 1987, 153:163-169.
17. Riley G.P., Goddard M.J., Hazleman B.L. Histopathological assessment and pathological significance of matrix degeneration in supraspinatus tendons. Rheumatology 2001, 40:229-230.
18. Riley G.P., Curry V., DeGroot J., Van El B., Verzijl N., Hazleman B.L., et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002, 21:185-195.
19. Langberg H., Olesen J., Skovgaard D., Kjaer M: Age related blood flow around the Achilles tendon during exercise in humans. Eur J Appl Physiol 2001, 84:246-248.
20. Dalal M., Ferrucci L., Sun K., Beck J., Fried L.P., Semba R.D. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci 2009, 64:132-137.
21. Grant W.P., Sullivan R., Sonenshine D.E., Adam M., Slusser J.H., Carson K.A., Vinik A.I. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg 1997, 36:272-278.
22. Abate M., Gravare-Silbernagel K., Siljeholm C., Di Iorio A., De Amicis D., Salini V., Werner S., Paganelli R. Pathogenesis of tendinopathies: inflammation or degeneration? Review. Arthritis Res Ther 2009, 11:235.
23. Reddy G.K., Stehno-Bittel L., Enwemeka C.S. Glycation-induced matrix stability in the rabbit Achilles tendon. Arch Biochem Biophys 2002, 399:174-180.
24. Twigg S.M., Chen M.M., Joly A.H., Chakrapani S.D., Tsubaki J., Kim H.S., Oh Y., Rosenfeld R.G. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus. Endocrinology 2001, 142:1760-1769.
25. Batista F., Nery C., Pinzur M., Monteiro A.C., de Souza E.F., Felippe F.H., Alcântara M.C., Campos R.S. Achilles tendinopathy in diabetes mellitus. Foot Ankle Int 2008, 29:498-501.
26. Jung Ho-Joong, Fisher Matthew B., Woo Savio L.-Y. Role of biomechanics in the understanding of normal, injured, and healing ligaments and tendons, Review. Sports Med Arthrosc Rehabil Ther Technol 2009, 1:9. 10.1186/1758-2555-1-9.
27. Woo S.L.-Y., Orlando C.A., Gomez M.A., Frank C.B., Akeson W.H. Tensile properties of the medial collateral ligament as a function of age. J Orthop Res 1986, 4:133-141.
28. Woo S.L.-Y., Ohland K.J., Weiss J.A. Aging and sex-related changes in the biomechanical properties of the rabbit medial collateral ligament. Mech Ageing Dev 1990, 56:129-142.
29. Cook J.L., Khan K.M., Kiss Z.S., Griffiths L: Patellar tendinopathy in junior basketball players: a controlled clinical and ultrasonographic study of 268 patellar tendons in players aged 14-18 years. Scand J Med Sci Sports 2000, 10(4):216-220.
30. Kannus P., Niittymaki S., Jarvinen M: Recent trends in women's sports injuries. J Sports Traumatol 1990, 3:161-167.
31. Wilber C.A., Holland G.J., Madison R.E., Loy S.F. An epidemiological analysis of overuse injuries among recreational cyclists. Int J Sports Med 1995, 16(3):201-206.
32. Holmes G.B., Lin J. Etiologic factors associated with symptomatic Achilles tendinopathy. Foot Ankle Int 2006, 27:952-959.
33. Landry S.C., McKean K.A., Hubley-Kozey C.L., Stanish W.D., Deluzio K.J. Neuromuscular and lower limb biomechanical differences exist between male and female elite adolescent soccer players during an unanticipated side-cut maneuver. Am J Sports Med 2007, 35:1888-1900.
34. Wentorf F.A., Sudoh K., Moses C., Arendt E.A., Carlson C.S. The effects of estrogen on material and mechanical properties of the intra-and extra-articular knee structures. Am J Sports Med 2006, 34:1948-1952.
35. Miller B.F., Hansen M., Olesen J.L., Schwarz P., Babraj J.A., Smith K., et al. Tendon collagen synthesis at rest and after exercise in women. J Appl Physiol 2007, 102:541-546.
36. Moalli P.A., Talarico L.C., Sung V.W., Klingensmith W.L., Shand S.H., Meyn L.A., et al. Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis. Am J Obstet Gynecol 2004, 190:620-627.
37. Westh E., Kongsgaard M., Bojsen-Moller J., Aagaard P., Hansen M., Kjaer M., et al. Effect of habitual exercise on the structural and mechanical properties of human tendon, in vivo, in men and women. Scand J Med Sci Sports 2008, 18:23-30.
38. Knobloch K., Schreibmueller L., Kraemer R., Jagodzinski M., Vogt P.M., Redeker J. Gender and eccentric training in Achilles mid-portion Tendinopathy. Knee Surg Sports Traumatol Arthrosc 2010, 18:648-655. DOI: 10 1007/s00167-009-1006-7.
39. Kraemer R., Wuerfel W., Lorenzen J., Busche M., Vogt P.M., Knobloch K. Analyisis of hereditary and medical risk factors in Achilles tendinopathy and Achilles tendon ruptures: a matched pair analysis. Arch Orthop Trauma Surg 2012, 132:847-853.
40. Geyer M. Achillodynie. Orthopade Chirurgie 2005, 34:677-681.
41. Ker R.F. Dynamic tensile properties of the plantaris tendon of sheep (Ovis aries). J Exp Biol 1981, 93:283-302.
42. Riemersma D.J., Schamhardt H.C. In vitro mechanical properties of equine tendons in relation to cross-sectional area and collagen tendon. Res Vet Sci 1985, 39:263-270.
43. Birch H.L., Wilson A.M., Goodship A.E. The effect of exercise-induced localized hyperthermia on tendon cell survival. J Exp Biol 1997, 200:1703-1708.
44. Arancia G., Crateri Trovalusci P., Mariutti G., Mondovi B. Ultrastructural changes induced by hyperthermia in Chinese hamster V79 fybroblasts. Int J Hyperthermia 1989, 5(3):34150.
45. Jozsa L., Kannus P. Tendon alterations in inherited diseases. Human tendons: anatomy, physiology and pathology 1997, 390-402. Human Kinetics, Champaigns. L. Jozsa, P. Kannus (Eds.).
46. Jozsa L., Kannus P. Tendon alterations in endocrinologic and metabolic diseases. Human tendons: anatomy, physiology and pathology 1997, 403-412. Human Kinetics, Champaign. L. Jozsa, P. Kannus (Eds.).
47. Jozsa L., Kannus P. Tendon alterations in rheumatic diseases. Human tendons: anatomy, physiology and pathology 1997, 412-429. Champaign, Human Kinetics. L. Jozsa, P. Kannus (Eds.).
48. Mahieu N.N., Witvrouw E., Stevens V., Van Tiggelen D., Roget P. Intrinsic risk factors for the development of Achilles tendon overuse injury: a prospective study. Am J Sports Med 2006, 34:226-235.
49. Vailas A.C., Tipton C.M., Laughlin H.L., Tcheng T.K., Matthes R.D. Physical activity and hypophysectomy on the aerobic capacity of ligaments and tendons. J Appl Physiol 1978, 44(4):542-546.
50. Pufe T., Petersen W., Tillmann B., Mentlein R. The angiogenic peptide vascular endothelial cell growth factor (VEGF) is expressed in fetal and ruptured tendons. Virchows Arch 2001, 439:579-585.
51. Pufe T., Petersen W., Kurz B., Tsokos M., Tillmann B., Mentlein R. Mechanical factors influence the expression of endostatin -an inhibitor of angiogenesis - in tendons. J Orthop Res 2003, 21:610-616.
52. O'Reilly M.S., Behm T., Sing Y., Fikai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
53. Pufe T., Petersen W., Goldring M.B., Mentlein R., Varoga D., Tsokos M., Tillmann B. Endostatin - an inhibitor of angiogenesis-is expressed in human cartilage and fibrocartilage. Matrix Biol 2004, 23:267-276.
54. Dhanabal M., Ramachandran R., Waterman M.J., Lu H., Knebelman B., Segal M., Sukhatme V.P. Endostatin induces endothelial cell apoptosis. J Biochem 1999, 274:11721-11726.
55. Lesic A., Bumbasirevic M. Disorders of the Achilles tendon. Curr Orthop 2004, 18:63-75.
56. Niculescu V., Matusz P. The clinical importance of the calcaneal tendon vasculature (tendocalcaneus). Morphol Embryol (Bucur) 1988, 34:5-8.
57. Zantop T., Tillmann B., Petersen W. Quantitative assessment of blood vessels of the human Achilles tendon: an immunohistochemical cadaver study. Arch Orthop Trauma Surg 2003, 123:501-504.
58. Astrom M. Laser Doppler flowmetry in the assessment of tendon blood flow. Scand J Med Sci Sports 2000, 10:365-367.
59. Alfredson H., Bjur D., Thorsen K., Lorentzon R., Sandstrom P. High intratendinous lactate levels in painful chronic Achilles tendinosis. An investigation using microdialysis technique. J Orthop Res 2002, 20:934-938.
60. Leadbetter W.B. Cell-matrix response in tendon injury. Clin Sports Med 1992, 11:533-542.
61. Bestwick C.S., Maffulli N. Reactive oxygen species and tendon problems: review and hypothesis. Sports Med Arthroscopy Rev 2000, 8:6-16.
62. Wang M.X., Wei A., Yuan J., Clippe A., Bernard A., Knoops B., Murrell G.A. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem Biophys Res Commun 2001, 284(3):667-673.
63. Petersen W., Pufe T., Unterhauser F., Zantop T., Mentlein R., Weiler A: The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing. Arch Orthop Trauma Surg 2003, 123:475-480.
64. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999, 77:527-543.
65. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
66. Alfredson H., Lorentzon M., Backman S., Backman A., Lerner U.H. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res 2003, 21(6):970-975.
67. Ireland D., Harrall R., Curry V., Holloway G., Hackney R., Hazleman B., Riley G. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001, 20(3):159-169.
68. Petersen W., Pufe T., Zantop T., Tillmann B., Tsokos M., Mentlein R. Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. Clin Orthop 2004, 420:286-291.
69. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., Anand-Apte B: A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003, 9:407-415.
70. Millar N.L., Reilly J.H., Kerr S.C., Campbell A.L., Little K.J., Leach W.J., Rooney B.P., Murrell G.A.C., McInnes I.B. Hypoxia: a critical regulator of early human tendinopathy; Extended report. Ann Rheum Dis 2012, 71:302-310. 10.1136/ard.2011.154229.
71. Raleigh S.M., Collins M. Gene variants that predispose to Achilles tendon injuries: an update on recent advances. Achilles tendon January, 2012, InTech, ISBN 978-953-51-0264-9. A. Čretnik (Ed.).
72. Collins M., Raleigh S.M. Genetic risk factors for musculoskeletal soft tissue injuries. Med Sport Sci 2009, 54:136-149.
73. September A.V., Nell E.M., O'Connell K., Cook J., Handley C.J., van der Merwe L., Schwellnus M., Collins M A pathway-based approach investigating the genes encoding interleukin-1{beta}, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy. Br J Sports Med 2011, 45(October (13)):1040-1047.
74. Ribbans W.J., Collins M: Pathology of the tendo Achillis. Do our genes contribute?. Bone Joint J 2013, 95-B:305-313.
75. Williams R.J., Attia E., Wickiewicz T.L., Hannafin J.A. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med 2000, 28(3):364-369.
76. Marie I., Delafenetre H., Massy N., Thuillez C., Noblet C. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum 2008, 59:367-372.
77. Fredberg U: Local corticosteroid injection in sport: review of literature and guidelines for treatment. Scand J Med Sci Sports 1997, 7:131-139.
78. van der Linden P.D., Sturkenboom M.C., Herings R.M., Leufkens H.M., Rowlands S., Stricker B.H. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003, 163:1801-1807.
79. Kleinman M., Gross A.E. Achilles tendon rupture following steroid injection. Report of three cases. J Bone Joint Surg Am 1983, 65:1345-1347.
80. Ford L.T., DeBender J. Tendon rupture after local steroid injection. South Med J 1979, 72:827.30.
81. Kapetanos G. The effect of the local corticosteroids on the healing and biomechanical properties of the partially injured tendon. Clin Orthop Relat Res 1982, 163:170-179.
82. Maffulli N., Longo U.G., Denaro V. Novel approaches for the management of tendinopathy. Current concepts review. J Bone Joint Am 2010, 92:2604-2613.
83. Riley G.P., Cox M., Harrall R.L., Clements S., Hazleman B.L. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by nonsteroidal anti-inflammatory drugs in vitro. J Hand Surg Br 2001, 26(3):224-228.
84. Tsai W.C., Hsu C.C., Chang H.N., Lin Y.C., Lin M.S., Pang J.H. Ibuprofen upregulates expressions of matrix metalloproteinase-1, -8, -9, and -13 without affecting expressions of types I and III collagen in tendon cells. J Orthop Res 2010, 28(4):487-491.
85. Chan K.M., Fu S.C. Anti-inflammatory management for tendon injuries - friends or foes?. Sports Med Arthrosc Rehabil Ther Technol 2009, 1(1):23.
86. Maffulli N., Khan K.M., Puddu G. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy 1998, 14:840-843.
87. Selvanetti A., Cipolla M., Puddu G. Overuse tendon injuries: basic science and classification. Oper Tech Sports Med 1997, 5:110-117.
88. Arndt A.N., Komi P.V., Bruggemann G.P., Lukkariniemi J. Individual muscle contributions to the in vivo Achilles tendon force. Clin Biomech 1998, 13(7):532-541.
89. Yang G., Im H.J., Wang J.H. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene 2005, 363:166-172.
90. Riquet F.B., Lai W.F., Birkhead J.R., Suen L.F., Karsenty G., Goldring M.B. Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 2000, 6:705-719.
91. Kjaer M., Langberg H., Skovgaard D., Olesen J., Bulow J., Krogsgaard M., et al. In vivo studies of peritendinous tissue in exercise. Scand J Med Sci Sports 2000, 10:326-331.
92. Alfredson H., Forsgren S., Thorsen K., Lorentzon R: In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper's knee. J Orthop Res 2001, 19:881-886.
93. Benazzo F., Maffulli N. An operative approach to Achilles tendinopathy. Sports Med Arthroscopy Rev 2000, 8:96-101.
94. Millar N.L., Hueber A.J., Reilly J.H., Xu Y., Fazzi U.G., Murrell G.A., et al. Inflammation is present in early human tendinopathy. Am J Sports Med 2010, 38:2085-2091.
95. Andersson G., Danielson P., Alfredson H., Forsgren S. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept 2008, 150:81-87.
96. Danielson P., Alfredson H., Forsgren S. Immunohistochemical and histochemical findings favoring the occurrence of autocrine/paracrine as well as nerve-related cholinergic effects in chronic painful patellar tendon tendinosis. Microsc Res Tech 2006, 69:808-819.
97. Bjur D., Danielson P., Alfredson H., Forsgren S. Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res 2008, 331:385-400.
98. Hart D.A., Kydd A., Reno C. Gender and pregnancy affect neuropeptide responses of the rabbit Achilles tendon. Clin Orthop 1999, 365:237-246.
99. Hart D.A., Frank C.B., Bray R.C. Inflammatory processes in repetitive motion and overuse syndromes: potential role of neurogenic mechanisms in tendons and ligaments. Repetitive motion disorders of the upper extremity 1995, 247-262. American Academy of Orthopaedic Surgeons, Rosemont. S.L. Gordon, S.J. Blair, L.J. Fine (Eds.).
100. Shalabi A. Magnetic resonance imaging in chronic Achilles tendinopathy. Acta Radiol Suppl (Stockholm) 2004, 1-45.
101. Paavola M., Kannus P., Paakkala T., Pasanen M., Jarvinen M. Long-term prognosis of patients with achilles Tendinopathy. An observational 8-year follow-up study. Am J Sports Med 2000, 28:634-642.
102. Bileviciute I., Lundeberg T., Ekblom A., Thedorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fl uid during acute monoarthritis. Neurosci Lett 1993, 153:37-40.
103. Bileviciute I., Stenfors C., Theodorsson E., Lundeberg T. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw. Br J Pharmacol 1998, 125:1304-1312.
104. Andersson G., Forsgren S., Scott A., Gaida J.E., Stjernfeldt J.E., Lorentzon R., Alfredson H., Backman C., Danielson P. Tenocyte hypercellularity and vascular proliferation in a rabbit model of tendinopathy: contralateral effects suggest the involvement of central neuronal mechanisms. Br J Sports Med 2011, 45:399-406. 10.1136/bjsm.2009.068122.
105. Yang G., Crawford R.C., Wang J.H. Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions. J Biomech 2004, 37:1543-1550.
106. Cilli F., Khan M., Fu F., Wang J.H. Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin J Sport Med 2004, 14:232-236.
107. Nell E.-M., van der Merwe L., Cook J., Handley C.J., Collins M., September A.V. The apoptosis pathway and the genetic predisposition to Achilles tendinopathy. J Orthop Res 2012, Published online in Wiley Online Library (wileyonlinelibrary.com). 10.1002/jor.22144.
108. Scott A., Khan K.M., Heer J., Cook J.L., Lian O., Duronio V. High strain mechanical loading rapidly induces tendon apoptosis: an ex vivo rat tibialis anterior model. Br J Sports Med 2005, 39:e25.
109. Clancy W. Failed healing resposes in sports-induced inflammation: clinical and basic science concepts 1989, American Orthopedic Society for Sports Medicine, Park Ridge, IL. W. Leadbetter, J. Buckwater, S. Gordon (Eds.).
110. Xu Y., Murrell G.A. The basic science of tendinopathy. Clin Orthop Relat Res 2008, 466:1528-1538.
111. Hashimoto S., Takahashi K., Ochs R.L., Coutts R.D., Amiel D., Lotz M. Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum 1999, 42:2123-2131.
112. Szomor Z.L., Appleyard R.C., Murrell G.A. Overexpression of nitric oxide synthases in tendon overuse. J Orthop Res 2006, 24:80-86.
113. Bokhari A.R., Murrell G.A.C. The role of nitric oxide in tendon healing. J Shoulder Elbow Surg 2012, 21:238-244.
114. Xia W., Szomor Z., Wang Y., Murrell G.A. Nitric oxide enhances collagen synthesis in cultured human tendon cells. J Orthop Res 2006, 24:159-172.
115. Paoloni J., Murrell G.A.C. Three-year followup study of topical glyceryl trinitrate application in the treatment of chronic noninsertional Achilles tendinopathy. Foot Ankle Int 2007, 28:1064-1068.
116. Notaricola A., Pesce V., Vicenti G., Tafuri S., Forcignanò M., Moretti B: SWAAT Study: Extracorporeal shock wave therapy and arginine supplementation and other nutraceuticals for insertional Achilles tendinopathy. Adv Ther 2012, 29(9):799-814.
117. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13:1219-1227.
118. Zhang J., Wang J.H. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 2010, 11:10.
119. Zhang J., Pan T., Liu Y., Wang J.H. Mouse treadmill running enhances tendons by expanding the pool of tendon stem cells (TSCs) and TSC-related cellular production of collagen. J Orthop Res 2010, 28:1178-1183.
120. Zhang J., Wang J.H. Mechanobiological response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy. J Orthop Res 2010, 28:639-643.
121. Divani K., Chan O., Padhiar N., Twycross-Lewis R., Maffulli N., Crisp T., Morrissey D. Site of maximum neovascularisation correlates with the site of pain in recalcitrant mid-tendon Achilles tendinopathy. Man Ther 2010, 15:463-468.
122. Peers K.H., Brys P.P., Lysens R.J. Correlation between power Doppler ultrasonography and clinical severity in Achilles tendinopathy. Int Orthop 2003, 27:180-183.
123. Zanetti M., Metzdorf A., Kundert H.P., Zollinger H., Vienne P., Seifert B., Hodler J. Achilles tendons: clinical relevance of neovascularization diagnosed with power Doppler US. Radiology 2003, 227:556-560.
124. Bjur D., Alfredson H., Forsgren S. The innervation pattern of the human Achilles tendon: studies of the normal and tendinosis tendon with markers for general and sensory innervation. Cell Tissue Res 2005, 320:201-206.
125. Forsgren S., Danielson P., Alfredson H. Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: studies on chemically unfixed as well as fixed specimens. Regul Pept 2005, 126:173-181.
126. Alfredson H., Forsgren S., Thorsen K., Fahlstrom M., Johansson H., Lorentzon R. Glutamate NMDAR1 receptors localised to nerves in human Achilles tendons. Implications for treatment?. Knee Surg Sports Traumatol Arthrosc 2001, 9:123-126.
127. Andersson G., Danielson P., Alfredson H., Forsgren S. Nerve-related characteristics of ventral paratendinous tissue in chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc 2007, 15:1272-1279.
128. Steenstra F., van Dijk C.N. Achilles tendoscopy. Foot Ankle Clin 2006, 11:429-438.
129. Gibbon W.W., Cooper J.R., Radcliffe G.S. Distribution of sonographically detected tendon abnormalities in patients with a clinical diagnosis of chronic achilles tendinosis. J Clin Ultrasound 2000, 28:61-66.
130. van Schie H.T., de Vos R.J., de J.S., Bakker E.M., Heijboer M.P., Verhaar J.A., Tol J.L., Weinans H. Ultrasonographic tissue characterisation of human Achilles tendons: quantification of tendon structure through a novel non-invasive approach. Br J Sports Med 2010, 44:1153-1159.
131. Daseler EH: The plantaris muscle: an anatomical study of 750 specimens. J Bone Joint Surg 1943, 25:822-827.
132. Tudor-Locke C., Hatano Y., Pangrazi R.P., Kang M. Revisiting "how many steps are enough?". Med Sci Sports Exerc 2008, 40:S537-S543.
133. Linz F., Higgs A., Millet M., Barton T., Raghuvanshi M., Adams M.A., Winson I.G. The role of Plantaris Longus in Achilles tendinopathy: a biomechanical study. Foot Ankle Surg 2011, 17:252-255.
134. Alfredson H: Midportion Achilles tendinosis and the plantaris tendon. Br J Sports Med 2011, 45:1023-1025.
135. Luck M.D., Gordon A.G., Blebea J.S., Dalinka M.K. High association between accessory soleos muscle and Achilles tendinopathy. Skeletal Radiol 2008, 37:1129-1133.
136. Padhiar N., Al-Sayeagh H., Chan O., King J., Maffulli N. Pennation angle of the soleus in patients with unilateral Achilles tendinopathy. Disabil Rehabil 2008, 30:1640-1645.
137. Longo U.G., Ronga M., Maffulli N: Achilles tendinopathy. Sports Med Arthrosc 2009, 17:112-126.
138. Cook J.L., Purdam C.R. Is tendon pathology a continuum? A pathology model to explain the clinic al presentation of load-induced tendinopathy. Review. Br J Sports Med 2009, 43:409-416. 10.1136/bjsm.2008.051193.
139. Rompe J.D., Furia J.P., Maffulli N: Mid-portion Achilles tendinopathy - current options for treatment. Disabil Rehabil 2008, 30:1666-1676.